Strong Core Business, Raised Guidance Push Vertex Pharmaceuticals Higher

Since 2008, Vertex Pharmaceuticals, Inc. (VRTX) shares have received 42 outlier institutional inflow signals and gained over 1,682%.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。